Citation Impact
Citing Papers
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus
2003
The Presence of Foxp3 Expressing T Cells Within Grafts of Tolerant Human Liver Transplant Recipients
2008 StandoutNobel
The Pharmacogenetics of Immunosuppression for Organ Transplantation
2003
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1
2001
Adult Living Donor Liver Transplantation: the Hepatologist's Perspective
2001
Cytochrome P450 3A
1999
Herb-drug interactions
2000 Standout
Liver fibrosis – from bench to bedside
2003 Standout
Role of HLA compatibility in pediatric living-related liver transplantation1
2002
Time-Related Clinical Determinants of Long-Term Tacrolimus Pharmacokinetics in Combination Therapy with Mycophenolic Acid and Corticosteroids
2004
Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center
2006
Oral Anticoagulant Therapy
2012 Standout
Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation
2016 StandoutNobel
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Hydrogel: Preparation, characterization, and applications: A review
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation
2004 StandoutNobel
The Generation of Donor-Specific CD4+CD25++CD45RA+ Naive Regulatory T Cells in Operationally Tolerant Patients After Pediatric Living-Donor Liver Transplantation
2010 StandoutNobel
Maturation of Dose-Corrected Tacrolimus Predose Trough Levels in Pediatric Kidney Allograft Recipients
2008
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement
2002
PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1
1998
Insulin-like growth factor 1: A novel treatment for the protection or regeneration of cochlear hair cells
2015
Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)*1
1999
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients
2008
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Current strategies for the use of sub-optimal grafts in living donor liver transplantation
2002 StandoutNobel
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the and genes
2004
Clinical Pharmacokinetics of Tacrolimus
1995 Standout
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
Role of P-Glycoprotein Inhibition for Drug Interactions
2007
Apheresis Therapy for Living‐Donor Liver Transplantation
2002 StandoutNobel
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
Controlled Delivery of Basic Fibroblast Growth Factor Promotes Human Cardiosphere-Derived Cell Engraftment to Enhance Cardiac Repair for Chronic Myocardial Infarction
2008
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction
2000
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
2010 StandoutNobel
Unmasking the Dynamic Interplay between Intestinal P-Glycoprotein and CYP3A4
2002
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats
2007 StandoutNobel
Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation
2001
MODULATION OF P-GLYCOPROTEIN EXPRESSION IN HYPERTHYROID RAT TISSUES
2005
Herb-Drug Interactions
2005 Standout
Impact of Drug Transporter Studies on Drug Discovery and Development
2003
Herbal Medicines and Perioperative Care
2001 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
2003
Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
2010
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Interactions Between Herbal Medicines and Prescribed Drugs
2001 Standout
Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance
2001
The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation
2005 StandoutNobel
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Association of the Multidrug Resistance-1 Gene Single-Nucleotide Polymorphisms with the Tacrolimus Dose Requirements in Renal Transplant Recipients
2003
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Epstein–Barr Virus Infection
2000 Standout
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation
2006 StandoutNobel
Therapeutic Angiogenesis in the Management of Critical Limb Ischemia
2009
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein)
2007
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
The Pharmacogenetics of Calcineurin Inhibitors: One Step Closer Toward Individualized Immunosuppression?
2005
Clinical consequences of polypharmacy in elderly
2013 Standout
C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation
2002
Biliary complications in pediatric living related liver transplantation
1998 StandoutNobel
Vascular Responses to Hypoxia and Ischemia
2009 StandoutNobel
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
2002 Standout
Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering
2010 Standout
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
2000 Standout
Tacrolimus
2000
Biomaterial technology for tissue engineering applications
2009
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
2013 Standout
St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties
2001 Standout
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
IMPACT OF GRAFT SIZE MISMATCHING ON GRAFT PROGNOSIS IN LIVER TRANSPLANTATION FROM LIVING DONORS1,2
1999
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Membrane transporter proteins: a challenge for CNS drug development
2006
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
Works of Tohru Hashida being referenced
生物分解ゼラチンヒドロゲルを用いた塩基性線維芽細胞成長因子の持続遊離による重大な肢虚血患者に対する治療血管新生の新しい方法 第I-IIa試験の最初の報告
2007
Effect of clarithromycin on renal excretion of digoxin: Interaction with P-glycoprotein*
1998
THE EVOLUTION OF IMMUNOSUPPRESSION WITH FK506 IN PEDIATRIC LIVING-RELATED LIVER TRANSPLANTATION1
1996
Pharmacokinetics of FK 506 in living-related liver transplantation.
1996
A Novel Approach to Therapeutic Angiogenesis for Patients With Critical Limb Ischemia by Sustained Release of Basic Fibroblast Growth Factor Using Biodegradable Gelatin Hydrogel An Initial Report of the Phase I-IIa Study
2007
Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation
2001
Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living‐donor liver transplantation
2001
Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations.
1995